BREASTOX
Live / Applied — New application — not yet assigned to an examiner (as of 20 Mar 2026)
What this means for you
Not registered yet, but its 20 Mar 2026 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99715466
- Mark type
- Stylized text
- Filed
- 20 Mar 2026
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: Specimen collection kits for the collection of saliva for use in DNA screening and genetic testing for medical purposes comprised primarily of swabs, collection tubes with caps, all with or without stabilizing reagents and with instructions, printed mailing labels and flat pack cardboard mailing boxes
- Class 009 — Scientific and electric apparatus: DNA collection kit comprised of DNA collection laboratory swab and swab handle
- Class 010 — Medical apparatus: Specimen collection kits for use in genetic testing comprised primarily of saliva containers for medical purposes sold empty, instructions, shipping labels and transport packaging; Medical diagnostic apparatus for testing and analysis of DNA and genetic samples for medical purposes; Medical specimen collection devices in the nature of empty tubes and vials for the collection of DNA samples for use in medical testing and analysis of genetics; Saliva collection devices for medical purposes
- Class 042 — Scientific and technological services: Research and development for the purpose of determining treatment selection for breast cancer
- Class 044 — Medical, beauty and agricultural services: Medical and laboratory analysis in connection with the treatment of patients; Processing medical test kits and home sample collection kits; medical testing of saliva and blood; Medical testing for diagnostic or treatment purposes; Genetic testing for medical purposes; medical testing for predicting toxicity in connection with radiation treatments; Medical consultancy services; Medical risk assessment services in the nature of predicting toxicity in connection with radiation treatments
Owner
- Mira DX, Inc., Los Angeles, CA, US
Prosecution history
- 20 Mar 2026 — APPLICATION FILING RECEIPT MAILED
- 20 Mar 2026 — NEW APPLICATION ENTERED